Jacques Servier

Jacques Servier (9 February 1922 – 16 April 2014) was a French doctor and businessman. He was the founder and president of Laboratoires Servier, a pharmaceutical company.[1]

Jacques Servier
Born(1922-02-09)9 February 1922
Died16 April 2014(2014-04-16) (aged 92)
NationalityFrench
OccupationBusinessman
Founder of Laboratoires Servier

Biography

Founder of the pharmaceutical group Servier in 1954, he had a fortune estimated at US$7.7 billion.[2]

The group led by him, Servier, had been convicted several times to pay damages for Mediator, trade name of benfluorex. There was a class action also for Isoméride, trade name of dexfenfluramine. There are also active discussions and trial around benfluorex.[3][4]

Decorations

References

  1. Bloomberg BusinessWeek
  2. "Jacques Servier - Forbes". Forbes. Retrieved 16 April 2014.
  3. "French patients sue over weight-loss drug linked to deaths". The Guardian. 24 November 2010.
  4. Mullard A (March 2011). "Mediator scandal rocks French medical community" (PDF). Lancet. 377 (9769). pp. 890–892. PMID 21409784. Archived from the original (PDF) on 2012-05-25.
  5. "Sarkozy vows health system fix after drug furore". AlertNet. 20 January 2011. Archived from the original on 14 June 2012. Retrieved 24 September 2011.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.